Neuberger Berman Group LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$68,432,154
-20.1%
1,487,979
-0.2%
0.06%
-19.5%
Q2 2023$85,646,621
+429.6%
1,490,284
+245.6%
0.08%
+413.3%
Q1 2023$16,171,950431,2520.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders